2
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Other solid neoplasm
1
Genitourinary
1
Gastrointestinal
1
CNS
1
Conditions
Lymphoma
10
Neutropenia
8
Breast Neoplasms
8
Leukemia, Myeloid, Acute
7
Multiple Myeloma
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Lymphoma, Non-Hodgkin
4
Hematologic Neoplasms
4
Febrile Neutropenia
4
Leukemia, Monocytic, Acute
3
Leukemia, Biphenotypic, Acute
3
Hodgkin Disease
3
Uterine Cervical Neoplasms
2
Small Cell Lung Carcinoma
2
Sarcoma, Ewing
2
Sarcoma
2
Rhabdomyosarcoma
2
Osteosarcoma
2
Myelodysplastic Syndromes
2
Leukemia, Myelomonocytic, Chronic
2
Wilms Tumor
1
Triple Negative Breast Neoplasms
1
Thoracic Neoplasms
1
Teratoma
1
Solid Tumors
1
Sarcoma, Myeloid
1
Sarcoma, Clear Cell
1
Rhabdoid Tumor
1
Retinoblastoma
1
Renal Pelvis and Ureter Urothelial Carcinoma
1
Interventions
Cyclophosphamide
4
Topotecan
3
Ifosfamide
3
Doxorubicin
3
seclidemstat
2
pazopanib
2
Biopsy
2
tebentafusp
1
selinexor
1
pembrolizumab
1
pegylated granulocyte colony-stimulating factor
1
fludarabine phosphate
1
fludarabine
1
dostarlimab
1
devimistat
1
cobimetinib
1
cabozantinib
1
atezolizumab
1
Zoledronic Acid
1
X-Rays
1
Vemurafenib
1
Sunitinib
1
Specimen Handling
1
Sirolimus
1
Simvastatin
1
Radiotherapy, Image-Guided
1
Radiotherapy
1
Radiation Dose Hypofractionation
1
Radiation
1
Proton Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Sarcoma, Clear Cell
×
pegylated granulocyte colony-stimulating factor
×
Clear all
NCT02390843
2020-04-03
AflacST1402
Emory University
Phase 1
Completed
13 enrolled